was read the article
array:24 [ "pii" => "S1579212916000689" "issn" => "15792129" "doi" => "10.1016/j.arbr.2016.02.017" "estado" => "S300" "fechaPublicacion" => "2016-07-01" "aid" => "1307" "copyright" => "SEPAR" "copyrightAnyo" => "2016" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Arch Bronconeumol. 2016;52:354-60" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 3233 "formatos" => array:3 [ "EPUB" => 165 "HTML" => 2273 "PDF" => 795 ] ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S030028961600017X" "issn" => "03002896" "doi" => "10.1016/j.arbres.2015.11.019" "estado" => "S300" "fechaPublicacion" => "2016-07-01" "aid" => "1307" "copyright" => "SEPAR" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Arch Bronconeumol. 2016;52:354-60" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 4729 "formatos" => array:3 [ "EPUB" => 131 "HTML" => 3663 "PDF" => 935 ] ] "es" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original</span>" "titulo" => "¿Cuál es el nivel óptimo de presión espiratoria positiva (PEP) capaz de mejorar la tolerancia a la deambulación de los pacientes con enfermedad pulmonar obstructiva cronica (EPOC) grave?" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "354" "paginaFinal" => "360" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Is there an optimal level of positive expiratory pressure (PEP) to improve walking tolerance in patients with severe COPD?" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1209 "Ancho" => 1712 "Tamanyo" => 123806 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Perfil del ensayo. 72 pacientes seleccionados/22 excluidos: 15 incapaces, 7 rechazaron participar/50 aleatorizados/PM6M (repetida dos veces)/PM6M con PEP de 10<span class="elsevierStyleHsp" style=""></span>cm de H<span class="elsevierStyleInf">2</span>O/PM6M con PEP de 1<span class="elsevierStyleHsp" style=""></span>cm de H<span class="elsevierStyleInf">2</span>O/PM6M con PEP de 10<span class="elsevierStyleHsp" style=""></span>cm de H<span class="elsevierStyleInf">2</span>O/PM6M con PEP de 1<span class="elsevierStyleHsp" style=""></span>cm de H<span class="elsevierStyleInf">2</span>O.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Davide Russo, Carla Simonelli, Mara Paneroni, Manuela Saleri, Ines Maria Grazia Piroddi, Francesco Cardinale, Michele Vitacca, Antonello Nicolini" "autores" => array:8 [ 0 => array:2 [ "nombre" => "Davide" "apellidos" => "Russo" ] 1 => array:2 [ "nombre" => "Carla" "apellidos" => "Simonelli" ] 2 => array:2 [ "nombre" => "Mara" "apellidos" => "Paneroni" ] 3 => array:2 [ "nombre" => "Manuela" "apellidos" => "Saleri" ] 4 => array:2 [ "nombre" => "Ines Maria Grazia" "apellidos" => "Piroddi" ] 5 => array:2 [ "nombre" => "Francesco" "apellidos" => "Cardinale" ] 6 => array:2 [ "nombre" => "Michele" "apellidos" => "Vitacca" ] 7 => array:2 [ "nombre" => "Antonello" "apellidos" => "Nicolini" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1579212916000689" "doi" => "10.1016/j.arbr.2016.02.017" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212916000689?idApp=UINPBA00003Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S030028961600017X?idApp=UINPBA00003Z" "url" => "/03002896/0000005200000007/v2_201606300036/S030028961600017X/v2_201606300036/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S157921291630057X" "issn" => "15792129" "doi" => "10.1016/j.arbr.2016.05.011" "estado" => "S300" "fechaPublicacion" => "2016-07-01" "aid" => "1311" "copyright" => "SEPAR" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Arch Bronconeumol. 2016;52:361-7" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2325 "formatos" => array:3 [ "EPUB" => 169 "HTML" => 1512 "PDF" => 644 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>" "titulo" => "Lack of Correlation Between Pulmonary and Systemic Inflammation Markers in Patients with Chronic Obstructive Pulmonary Disease: A Simultaneous, Two-Compartmental Analysis" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "361" "paginaFinal" => "367" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Ausencia de correlación entre marcadores de inflamación pulmonar y sistémica en pacientes con enfermedad pulmonar obstructiva crónica: un análisis bi-compartimental simultáneo" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0010" "etiqueta" => "Fig. 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 2194 "Ancho" => 2990 "Tamanyo" => 272534 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">Relationship between the degree of airflow limitation (FEV<span class="elsevierStyleInf">1</span>, % predicted) and inflammatory markers determined in serum.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Belen Núñez, Jaume Sauleda, Judith Garcia-Aymerich, Aina Noguera, Eduard Monsó, Federico Gómez, Esther Barreiro, Alicia Marín, Josep Maria Antó, Alvar Agusti" "autores" => array:11 [ 0 => array:2 [ "nombre" => "Belen" "apellidos" => "Núñez" ] 1 => array:2 [ "nombre" => "Jaume" "apellidos" => "Sauleda" ] 2 => array:2 [ "nombre" => "Judith" "apellidos" => "Garcia-Aymerich" ] 3 => array:2 [ "nombre" => "Aina" "apellidos" => "Noguera" ] 4 => array:2 [ "nombre" => "Eduard" "apellidos" => "Monsó" ] 5 => array:2 [ "nombre" => "Federico" "apellidos" => "Gómez" ] 6 => array:2 [ "nombre" => "Esther" "apellidos" => "Barreiro" ] 7 => array:2 [ "nombre" => "Alicia" "apellidos" => "Marín" ] 8 => array:2 [ "nombre" => "Josep Maria" "apellidos" => "Antó" ] 9 => array:2 [ "nombre" => "Alvar" "apellidos" => "Agusti" ] 10 => array:1 [ "colaborador" => "Members of the Phenotype Characterization and Evolution of Chronic Obstructive Pulmonary Disease (PAC-COPD) Study Group" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0300289616000211" "doi" => "10.1016/j.arbres.2016.01.003" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289616000211?idApp=UINPBA00003Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S157921291630057X?idApp=UINPBA00003Z" "url" => "/15792129/0000005200000007/v2_201606300030/S157921291630057X/v2_201606300030/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S1579212916000653" "issn" => "15792129" "doi" => "10.1016/j.arbr.2016.02.015" "estado" => "S300" "fechaPublicacion" => "2016-07-01" "aid" => "1304" "copyright" => "SEPAR" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Arch Bronconeumol. 2016;52:347-53" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 3739 "formatos" => array:3 [ "EPUB" => 142 "HTML" => 2579 "PDF" => 1018 ] ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>" "titulo" => "Postoperative Respiratory Exercises Reduce the Risk of Developing Pulmonary Complications in Patients Undergoing Lobectomy" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "347" "paginaFinal" => "353" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Los ejercicios respiratorios postoperatorios reducen el riesgo de complicaciones pulmonares en pacientes sometidos a lobectomía" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Ana Rodriguez-Larrad, Juan Manuel Vellosillo-Ortega, Carlos Ruiz-Muneta, Luis Carlos Abecia-Inchaurregui, Jesús Seco" "autores" => array:5 [ 0 => array:2 [ "nombre" => "Ana" "apellidos" => "Rodriguez-Larrad" ] 1 => array:2 [ "nombre" => "Juan Manuel" "apellidos" => "Vellosillo-Ortega" ] 2 => array:2 [ "nombre" => "Carlos" "apellidos" => "Ruiz-Muneta" ] 3 => array:2 [ "nombre" => "Luis Carlos" "apellidos" => "Abecia-Inchaurregui" ] 4 => array:2 [ "nombre" => "Jesús" "apellidos" => "Seco" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0300289616000144" "doi" => "10.1016/j.arbres.2015.11.017" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289616000144?idApp=UINPBA00003Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212916000653?idApp=UINPBA00003Z" "url" => "/15792129/0000005200000007/v2_201606300030/S1579212916000653/v2_201606300030/en/main.assets" ] "en" => array:21 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>" "titulo" => "Is There an Optimal Level of Positive Expiratory Pressure (PEP) to Improve Walking Tolerance in Patients With Severe COPD?" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "354" "paginaFinal" => "360" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Davide Russo, Carla Simonelli, Mara Paneroni, Manuela Saleri, Ines Maria Grazia Piroddi, Francesco Cardinale, Michele Vitacca, Antonello Nicolini" "autores" => array:8 [ 0 => array:3 [ "nombre" => "Davide" "apellidos" => "Russo" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 1 => array:3 [ "nombre" => "Carla" "apellidos" => "Simonelli" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 2 => array:3 [ "nombre" => "Mara" "apellidos" => "Paneroni" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 3 => array:3 [ "nombre" => "Manuela" "apellidos" => "Saleri" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 4 => array:3 [ "nombre" => "Ines Maria Grazia" "apellidos" => "Piroddi" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 5 => array:3 [ "nombre" => "Francesco" "apellidos" => "Cardinale" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 6 => array:3 [ "nombre" => "Michele" "apellidos" => "Vitacca" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 7 => array:4 [ "nombre" => "Antonello" "apellidos" => "Nicolini" "email" => array:1 [ 0 => "antonellonicolini@gmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] ] "afiliaciones" => array:3 [ 0 => array:3 [ "entidad" => "Unidad de Rehabilitación Respiratoria, Hospital di Sestri Levante ASL4, Chiavarese, Italy" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Unidad de Estadística, ASL4, Chiavarese, Italy" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Unidad de Rehabilitación Pulmonar, Fondazione S. Maugeri IRCCS, Lumezzane, BS, Italy" "etiqueta" => "c" "identificador" => "aff0015" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "¿Cuál es el nivel óptimo de presión espiratoria positiva (PEP) capaz de mejorar la tolerancia a la deambulación de los pacientes con EPOC grave?" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0010" "etiqueta" => "Fig. 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 1350 "Ancho" => 1636 "Tamanyo" => 80630 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Box plot of 6MWD without PEP (baseline), and using PEP1 and PEP10 cmH<span class="elsevierStyleInf">2</span>O.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">In patients with chronic obstructive pulmonary disease (COPD), exercise training is a core component of pulmonary rehabilitation, supported by high-level evidence.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> The 6-min walk test (6MWT) has been adopted as standard procedure for exercise capacity assessment in patients with pulmonary diseases.<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> It is a simple, widely used and reliable test, useful for evaluating the functional status and prognosis of patients with a wide variety of diseases and the effects of several interventions, such as rehabilitation, pharmacological therapy and oxygen supplementation.<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3–5</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">Patients with COPD tend to stop exercising because of dyspnea rather than leg fatigue.<a class="elsevierStyleCrossRefs" href="#bib0025"><span class="elsevierStyleSup">5,6</span></a> Their physical performance may be reduced by a significant ventilatory limitation to exercise, particularly if peripheral muscle strength is not impaired.<a class="elsevierStyleCrossRefs" href="#bib0035"><span class="elsevierStyleSup">7–9</span></a> Consequently, adjunctive strategies to improve exercise tolerance have been proposed, such as non-invasive ventilation<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">10</span></a> and the application of positive expiratory pressure (PEP).<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">11</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">PEP is applied at the mouth in order to counterbalance the dynamic compression of the airways that leads to exercise-induced pulmonary hyperinflation. In some patients with COPD, reduced elastic recoil and the presence of expiratory flow limitation lead to pulmonary hyperinflation. Patients may present increased residual volume at rest (static hyperinflation) and/or may develop hyperinflation under strain (dynamic hyperinflation), as the increase of the respiratory rate shortens the expiratory time.<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">12</span></a> Furthermore, airway dynamic compression may occur during expiration, especially at high flow rates. The equal pressure point (EPP) is shifted peripherally, resulting in an earlier closure of the peripheral airways with consequent air trapping. This phenomenon causes a gradual shift of the tidal volume (<span class="elsevierStyleItalic">V</span><span class="elsevierStyleInf">t</span>) to higher levels of functional residual capacity (FRC) and a progressive decrease in inspiratory capacity (IC). Dynamic pulmonary hyperinflation can be quantified by measuring that decrease in IC.<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">13</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">The application of PEP increases intraluminal airways pressure and moves the EPP back to the upper airways, reducing dynamic compression and subsequently limiting pulmonary hyperinflation.<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">11,14</span></a> A similar effect is obtained by pursed lip breathing (PLB), which can be considered spontaneous PEP.<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">15</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">In COPD patients, some studies investigated the effects of PEP on strength, endurance, lung volumes or walking exercise. Padkao et al.<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">14</span></a> showed that the use of a flow-dependent conical-PEP lengthens isotonic quadriceps strength exercise periods. It also produces an increase in slow vital capacity (SVC) and in IC (+200<span class="elsevierStyleHsp" style=""></span>ml, <span class="elsevierStyleItalic">P</span>=.05), with decreased pulmonary hyperinflation. Monteiro et al.<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">16</span></a> applied PEP using an oronasal mask after a submaximal treadmill exercise in moderate-to-severe COPD patients, reporting an increase in IC after exercise. Furthermore, Martin and Davenport<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">17</span></a> demonstrated that extrinsic 10<span class="elsevierStyleHsp" style=""></span>cmH<span class="elsevierStyleInf">2</span>O PEP reduced post-exercise dyspnea in COPD patients. More recently, in severe COPD patients, Nicolini et al.<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">11</span></a> found that an adjunctive 5<span class="elsevierStyleHsp" style=""></span>cmH<span class="elsevierStyleInf">2</span>O PEP, administered via mouthpiece during the execution of a 6MWT, significantly improved the distance covered, oxygen saturation, and heart rate.</p><p id="par0030" class="elsevierStylePara elsevierViewall">However, contrasting results were reported by Wibmer et al.,<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">18</span></a> who applied flow-dependent PEP ranging from 10 to 20<span class="elsevierStyleHsp" style=""></span>cmH<span class="elsevierStyleInf">2</span>O during the 6MWT in patients with stable mild-to-severe COPD. They showed that PEP reduced FRC and the residual volume (RV) after exercise, but the PEP group walked 30<span class="elsevierStyleHsp" style=""></span>m less than controls. Despite these reports, no studies have described the optimal level of PEP that could improve exercise tolerance.</p><p id="par0035" class="elsevierStylePara elsevierViewall">In this context, the main aim of our study was to investigate the effect of two different levels of PEP valve (1<span class="elsevierStyleHsp" style=""></span>cmH<span class="elsevierStyleInf">2</span>O vs 10<span class="elsevierStyleHsp" style=""></span>cmH<span class="elsevierStyleInf">2</span>O) on the distance covered during a 6MWT (6MWD), compared to the basal 6MWT performed without PEP, in patients with severe COPD (FEV<span class="elsevierStyleInf">1</span><50%). Secondary outcomes were the evaluation of PEP effects on pulmonary function, symptoms and vital parameters immediately after the 6MWT.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Methods</span><p id="par0040" class="elsevierStylePara elsevierViewall">This prospective, single-blind, randomized crossover study was performed at the Respiratory Rehabilitation Unit of Sestri Levante Hospital, Italy and the Pulmonary Rehabilitation Unit of Fondazione S. Maugeri IRCCS, Lumezzane, Brescia Italy, from January 2013 to October 2013.</p><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Patients</span><p id="par0045" class="elsevierStylePara elsevierViewall">We recruited 72 consecutive severe COPD subjects (FEV<span class="elsevierStyleInf">1</span><50%) referred to our hospitals as in- and outpatients. The inclusion criteria were: age older than 18 years, clinical stability with no changes in medication within two weeks prior the test, and no exacerbations for at least three weeks. Exclusion criteria were: history of bronchial asthma, severe bullous emphysema with history of spontaneous pneumothorax, absence of written consent, and orthopedic and neurological diseases limiting the ability to perform a 6MWT. Fifty patients were included in the study and 22 were excluded (15 were unable to perform 6MWT and 7 did not provide written informed consent). The protocol received approval from the Institutional Ethics Committee of ASL 4 Chiavarese, Italy and was carried out according to the Declaration of Helsinki. The study was registered as ChiCTR-TTRCC-12002761 <a id="intr0010" class="elsevierStyleInterRef" href="http://www.chi.ctr.org/">www.chi.ctr.org</a>.</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Study Protocol</span><p id="par0050" class="elsevierStylePara elsevierViewall">All patients underwent two baseline 6MWTs, a baseline spirometry and a whole-body plethysmography on the first day of admission to the rehabilitation facility. On the second day, we started the protocol and the subjects were randomized to two groups: Group 1 performed the 6MWT with an adjunctive PEP of 10<span class="elsevierStyleHsp" style=""></span>cmH<span class="elsevierStyleInf">2</span>O (PEP10) and Group 2 with an adjunctive PEP of 1<span class="elsevierStyleHsp" style=""></span>cmH<span class="elsevierStyleInf">2</span>O (PEP1). Each group then changed the test sequence in a crossover design.</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Instruments</span><p id="par0055" class="elsevierStylePara elsevierViewall">PEP was used during the development of the 6MWT. It was administered by a PEP-valve (PEEP Valve, Ambu, Denmark), which consists of an adjustable threshold-load expiratory pressure valve in the range 0–20<span class="elsevierStyleHsp" style=""></span>cmH<span class="elsevierStyleInf">2</span>O, applied on expiration in a 2-way circuit, with a valve that opens during inspiration. The 2-way circuit is connected to an oronasal mask via a 20-mm inner diameter and 100-mm length tube. As the 100<span class="elsevierStyleHsp" style=""></span>mm tube adds some degree of further resistance to patient exhalation, we calculated the total PEP applied at the mouth by including a manual manometer in the circuit. At rest, the expiratory resistance in the PEP10 group was set at 10<span class="elsevierStyleHsp" style=""></span>cmH<span class="elsevierStyleInf">2</span>O, while in the PEP1 group, resistance was set at 1<span class="elsevierStyleHsp" style=""></span>cmH<span class="elsevierStyleInf">2</span>O.</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Measurements</span><p id="par0060" class="elsevierStylePara elsevierViewall">All 6MWTs were performed according to the American Thoracic Society guidelines in a flat, straight, indoor corridor (30<span class="elsevierStyleHsp" style=""></span>m marked by colored tape at each end to indicate turnaround points).<a class="elsevierStyleCrossRefs" href="#bib0095"><span class="elsevierStyleSup">19,20</span></a> Oxygen saturation and heart rate were recorded continuously with a lightweight Bluetooth wireless oxymeter (Avant 9600, Nonin Medical Inc., US). Respiratory rate, dyspnea (assessed on a Borg scale) and distance walked in meters were recorded at the beginning and at the end of each test. The patients rested at least 1<span class="elsevierStyleHsp" style=""></span>h between each test.</p><p id="par0065" class="elsevierStylePara elsevierViewall">All patients performed a baseline spirometry and whole-body plethysmography (VMax 20 PFT Sensor Medics Yorba Linda, CA, US), according to American and European (ATS/ERS) guidelines.<a class="elsevierStyleCrossRef" href="#bib0105"><span class="elsevierStyleSup">21</span></a></p><p id="par0070" class="elsevierStylePara elsevierViewall">Furthermore, functional lung tests (slow and forced spirometries) were conducted using a portable spirometer (Spirolab III, Medical International Research, Italy). Measurements were obtained immediately at the beginning and within 1<span class="elsevierStyleHsp" style=""></span>min of the end of each 6MWT with PEP1 and PEP10.</p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Statistical Analysis</span><p id="par0075" class="elsevierStylePara elsevierViewall">Data analysis was performed with statistical software (Stata Statistical Software: Release 12. StataCorp LP. College Station, TX, US).</p><p id="par0080" class="elsevierStylePara elsevierViewall">Primary outcome was 6MWD with different PEP levels (PEP1, PEP10). Secondary outcomes were changes in respiratory functional measurements [dyspnea assessed by Borg scale, respiratory rate (RR), pulse-oxymetry] and spirometry measurements [slow vital capacity (SVC), inspiratory capacity (IC), forced vital capacity (FVC), expiratory reserve volume (ERV)]. A statistician not involved in the study generated the randomization schedule, using a randomization table from a computer software program. The randomization assignments were provided to the recruiting physician in sealed envelopes.</p><p id="par0085" class="elsevierStylePara elsevierViewall">Descriptive analyses are presented as mean±standard deviation. Spirometry parameters obtained in PEP1 and PEP10 tests were compared using by paired <span class="elsevierStyleItalic">t</span>-tests. Differences between the three conditions (baseline, PEP1, PEP10) were studied by ANOVA for repeated measures (Fisher's test). When significant differences were found, post-hoc analysis with paired <span class="elsevierStyleItalic">t</span>-test and Bonferroni correction was done.</p><p id="par0090" class="elsevierStylePara elsevierViewall">The investigators who performed the study data analysis were blinded to patient assignments.</p></span></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Results</span><p id="par0095" class="elsevierStylePara elsevierViewall">Seventy-two patients were initially recruited. Fifteen subjects were excluded because they were unable to perform the 6MWT and 7 subjects refused to participate, so the final sample comprised 50 subjects. <a class="elsevierStyleCrossRef" href="#tbl0010">Table 1</a> describes the clinical and anthropometrical characteristics of the study patients. The patients were relatively elderly, predominantly male, and had severe COPD. A quarter of them were receiving long-term oxygen therapy due to associated respiratory failure. All patients had also severe static pulmonary hyperinflation. All 50 patients completed the study. Patient disposition is described in <a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>.</p><elsevierMultimedia ident="tbl0010"></elsevierMultimedia><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0100" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">F</span>-test for primary outcome (6MWD) shows a significant difference in results among different PEP levels and baseline (<span class="elsevierStyleItalic">F</span>-test 0.02). Post-hoc analysis shows that the use of PEP1 and PEP10 produced an increase in walking distance (PEP1 <span class="elsevierStyleItalic">P</span><.002 and PEP10 <span class="elsevierStyleItalic">P</span><.018), compared to baseline. There was no significant difference between PEP1 and PEP10. <a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a> shows the box plots of 6MWD.</p><elsevierMultimedia ident="fig0010"></elsevierMultimedia><p id="par0105" class="elsevierStylePara elsevierViewall">All changes (end of 6MWT<span class="elsevierStyleHsp" style=""></span>−<span class="elsevierStyleHsp" style=""></span>baseline) in secondary outcomes are reported in <a class="elsevierStyleCrossRef" href="#tbl0015">Table 2</a>. We observed a tendency to decreased HR and increased RR in both PEP1 and PEP10 condition, compared to baseline, which did not reach statistical significance. No significant difference was found between PEP1 and PEP10 in changes in pulmonary function, symptoms and physiological variables.</p><elsevierMultimedia ident="tbl0015"></elsevierMultimedia><p id="par0110" class="elsevierStylePara elsevierViewall">A reduction in IC of 10% and/or >150<span class="elsevierStyleHsp" style=""></span>ml, compared to baseline was defined as dynamic hyperinflation.<a class="elsevierStyleCrossRefs" href="#bib0110"><span class="elsevierStyleSup">22,23</span></a> Ten subjects showed dynamic hyperinflation and 40 did not. In the 40 subjects without dynamic hyperinflation, we observed a significant change in the distance covered (Δ meters) if 1<span class="elsevierStyleHsp" style=""></span>cmH<span class="elsevierStyleInf">2</span>O PEP was applied. No significant change was found if 10<span class="elsevierStyleHsp" style=""></span>cmH<span class="elsevierStyleInf">2</span>O was applied. These results appear in <a class="elsevierStyleCrossRef" href="#tbl0020">Table 3</a>.</p><elsevierMultimedia ident="tbl0020"></elsevierMultimedia></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Discussion</span><p id="par0115" class="elsevierStylePara elsevierViewall">In this randomized crossover trial, conducted in patients with severe COPD, we found that the application of 1<span class="elsevierStyleHsp" style=""></span>cmH<span class="elsevierStyleInf">2</span>O PEP during the execution of 6MWT can improve the distance walked to the same extent as the application of 10<span class="elsevierStyleHsp" style=""></span>cmH<span class="elsevierStyleInf">2</span>O PEP, without affecting the cardiovascular response to exercise. We did not find any effect of PEP on dyspnea at the end of exercise and post-exertion lung dynamic volumes, particularly IC, SVC, FVC and ERV. Moreover, we found that the improvement of 6MWD is greater in patients with no or low dynamic hyperinflation when a low PEP is applied.</p><p id="par0120" class="elsevierStylePara elsevierViewall">So far, only two other crossover randomized trials have investigated the effects of a PEP device on 6MWD, with contrasting results.</p><p id="par0125" class="elsevierStylePara elsevierViewall">In 2013, Nicolini et al.<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">11</span></a> found that a threshold PEP of 5<span class="elsevierStyleHsp" style=""></span>cmH<span class="elsevierStyleInf">2</span>O improved the distance walked during the 6MWT in patients with moderate-to-severe COPD. They also demonstrated a significant improvement in post-exercise oxygen saturation and a decrease in peak heart rate during the 6MWT with PEP, compared to controls without devices. However, in the same year, Wibmer et al.<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">18</span></a> investigated the same kind of patients and found that, with a flow-dependent PEP in the range of 10–20<span class="elsevierStyleHsp" style=""></span>cmH<span class="elsevierStyleInf">2</span>O, patients walked 30.8<span class="elsevierStyleHsp" style=""></span>m less than the controls without devices (352±92<span class="elsevierStyleHsp" style=""></span>m with no PEP, 321±93<span class="elsevierStyleHsp" style=""></span>m with PEP, <span class="elsevierStyleItalic">P</span>=.001). In their study, they demonstrated the efficacy of flow-dependent PEP on lung dynamic volumes, as total lung capacity, FRC and RV were significantly reduced after the 6MWT with PEP, compared to control group.</p><p id="par0130" class="elsevierStylePara elsevierViewall">Although the three studies used different kinds of PEP, it seems that the application of lower pressures produces better results in terms of distance covered during the 6MWT. However, the “right” level of PEP during exercise is still largely understudied.</p><p id="par0135" class="elsevierStylePara elsevierViewall">In this context, Martin et al.<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">17</span></a> applied two levels of threshold PEP (13.8 and 2<span class="elsevierStyleHsp" style=""></span>cmH<span class="elsevierStyleInf">2</span>O) and demonstrated a significant decrease in dyspnea with the use of the higher level of PEP after a treadmill constant load test. However, these results cannot be compared with ours, because the authors applied PEP only after the conclusion of the exercise test, rather than during effort.</p><p id="par0140" class="elsevierStylePara elsevierViewall">Recently, Bhatt et al.<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">15</span></a> reported good results regarding exercise tolerance improvement in patients with severe COPD. They conducted a crossover trial investigating the effects of PLB on 6MWD and found that patients walked 34.9<span class="elsevierStyleHsp" style=""></span>m more if they breathed with volitional PLB, compared to breathing normally (<span class="elsevierStyleItalic">P</span>=.002), with a concomitant reduction in RR after the test. Furthermore, they investigated the diaphragm excursion with ultrasonography and found a correlation between the improvements in 6MWD and the increase of diaphragm excursion with PLB. The authors explain their findings by suggesting that the PLB imposes a control and slows the RR, breaking the vicious circle of air trapping and dynamic pulmonary hyperinflation. This might translate into less neuro-ventilatory dissociation and a reduced perception of dyspnea. Low pressure PEP can be expected to act in a similar way.</p><p id="par0145" class="elsevierStylePara elsevierViewall">As regards pulmonary function, low PEP has also been proposed for airway clearance in patients with COPD and hypersecretion. Venturelli et al.<a class="elsevierStyleCrossRef" href="#bib0120"><span class="elsevierStyleSup">24</span></a> studied a mechanical device which applies 1<span class="elsevierStyleHsp" style=""></span>cmH<span class="elsevierStyleInf">2</span>O PEP at the mouth. They reported a significant improvement of IC at rest when patients breathe into the PEP device, compared to controls (+19.5% and +2.2%, <span class="elsevierStyleItalic">P</span>=.044). However, no data are available during exercise.</p><p id="par0150" class="elsevierStylePara elsevierViewall">Monteiro<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">16</span></a> and Padkao<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">14</span></a> reported improvements in dynamic and static lung volumes, we cannot confirm the effect of PEP devices on post-exercise lung volumes. As we did not perform the spirometry immediately after the basal 6MWT, we do not have data on the behavior of the IC and the other lung volumes during the 6MWT without PEP. At present, we do not know if PEP produces any improvements in lung volumes compared to no PEP. We did not find any significant difference in the behavior of IC, SVC, ERV or FVC between PEP1 and PEP10. The application of low and high levels of PEP during the 6MWT proved to have the same effect on lung volumes.</p><p id="par0155" class="elsevierStylePara elsevierViewall">Nevertheless, in our “ad hoc” analysis, we found that the application of low level PEP produces a greater improvement in the distance covered in the group of patients with no dynamic hyperinflation, compared to the group of patients who presented dynamic hyperinflation. This was in line with the findings of Callens et al., who observed that change in IC after walking does not correlate with 6MWD.<a class="elsevierStyleCrossRef" href="#bib0125"><span class="elsevierStyleSup">25</span></a></p><p id="par0160" class="elsevierStylePara elsevierViewall">In conclusion, it is difficult to compare the effects of PEP on exercise tolerance in patients with COPD, because the published studies are too heterogeneous, and use a variety of exercise protocols, types and levels of PEP and outcome measures. In order to clarify the effects of PEP on lung mechanics, it would be useful to evaluate the effect of PEP during a standardized exercise capacity test, such as the cardiopulmonary exercise test. As already discussed by Wibmer et al.,<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">18</span></a> a better standardized evaluation of dynamic lung volumes, including at least some subsequent IC measures during the exercise, should also be carried out.</p><p id="par0165" class="elsevierStylePara elsevierViewall">Future studies should lead to a more practical utilization of PEP devices. The effects of low level PEP during aerobic and strength training protocols, in the mid to long term, merit investigation.</p><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Limitations of the Study</span><p id="par0170" class="elsevierStylePara elsevierViewall">Some limitations in the study were detected. Firstly, pulmonary function was not assessed directly during the test; instead there was an average delay of 1<span class="elsevierStyleHsp" style=""></span>min between the end of 6MWT and the execution of the spirometry. This could have led to an underestimation of the effects of PEP on lung function.</p><p id="par0175" class="elsevierStylePara elsevierViewall">Furthermore, two kinds of PEP devices were proposed: flow-dependent or threshold-load.<a class="elsevierStyleCrossRef" href="#bib0130"><span class="elsevierStyleSup">26</span></a> We used a threshold-load PEP valve, but studies comparing both devices have not yet been published.</p><p id="par0180" class="elsevierStylePara elsevierViewall">In 2012, Monteiro et al.<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">16</span></a> demonstrated in a controlled non-randomized trial that breathing in a PEP mask at 10<span class="elsevierStyleHsp" style=""></span>cmH<span class="elsevierStyleInf">2</span>O during a treadmill test lasting 20<span class="elsevierStyleHsp" style=""></span>min produces less dynamic pulmonary hyperinflation, compared to controls without PEP, in severe COPD patients. They demonstrated a significant increase in IC and less IC decrease after exercise with PEP, compared to the control group. In their protocol, they started the exercise with 10<span class="elsevierStyleHsp" style=""></span>cmH<span class="elsevierStyleInf">2</span>O PEP and, if this was not tolerated by the patient, they reduced resistance gradually to as low as 5<span class="elsevierStyleHsp" style=""></span>cmH<span class="elsevierStyleInf">2</span>O. They found that the mean tolerated PEP value was 8±1.5<span class="elsevierStyleHsp" style=""></span>cmH<span class="elsevierStyleInf">2</span>O. We did not define the highest PEP value tolerated by the patients, since PEP values higher than tolerated could limit the ability to exhale, worsening dynamic pulmonary hyperinflation, causing dyspnea and leading to poor results.</p><p id="par0185" class="elsevierStylePara elsevierViewall">Another limitation may be related to the type of test employed. During the 6MWT, patients are allowed to slow down or stop if needed, for example in case of severe dyspnea. Moreover, the patients choose the walking speed themselves. For these reasons, it is possible that dynamic hyperinflation is not addressed during the 6MWT.</p><p id="par0190" class="elsevierStylePara elsevierViewall">We also defined severe COPD as an inclusion criterion. If we had included patients who only had reduced IC during exercise, we may have found higher levels of significance.</p><p id="par0195" class="elsevierStylePara elsevierViewall">Finally, the minimum clinically important difference of the 6MWD has been previously established as 25<span class="elsevierStyleHsp" style=""></span>m<a class="elsevierStyleCrossRefs" href="#bib0135"><span class="elsevierStyleSup">27,28</span></a> and this threshold was not reached in our study. This could be due to the wide variability of the distance covered by the patients. However, even a small improvement obtained by having the patient breathe into a simple device, while not clinically relevant, may still indicate a correct strategy which merits further investigation.</p><p id="par0200" class="elsevierStylePara elsevierViewall">Furthermore, a sample size analysis was not carried out and it is possible that the number of patients may have been too small to obtain more significant results.</p></span></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0115">Conclusions</span><p id="par0205" class="elsevierStylePara elsevierViewall">In patients with severe COPD, the application of 1<span class="elsevierStyleHsp" style=""></span>cmH<span class="elsevierStyleInf">2</span>O PEP seems to improve the exercise tolerance to the same extent as 10<span class="elsevierStyleHsp" style=""></span>cmH<span class="elsevierStyleInf">2</span>O, with similar reported dyspnea. No effects were found on lung volumes after exercise. As previously reported protocols and levels and types of PEP vary widely, further studies are recommended to confirm our results and to clarify the mechanism of action on lung mechanics. Future studies should also investigate the effects of low levels of PEP on aerobic and strength training programs.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:10 [ 0 => array:3 [ "identificador" => "xres678879" "titulo" => "Abstract" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Background" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Methods" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Results" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Conclusions" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec684770" "titulo" => "Keywords" ] 2 => array:3 [ "identificador" => "xres678880" "titulo" => "Resumen" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0025" "titulo" => "Introducción" ] 1 => array:2 [ "identificador" => "abst0030" "titulo" => "Métodos" ] 2 => array:2 [ "identificador" => "abst0035" "titulo" => "Resultados" ] 3 => array:2 [ "identificador" => "abst0040" "titulo" => "Conclusiones" ] ] ] 3 => array:2 [ "identificador" => "xpalclavsec684769" "titulo" => "Palabras clave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 5 => array:3 [ "identificador" => "sec0010" "titulo" => "Methods" "secciones" => array:5 [ 0 => array:2 [ "identificador" => "sec0015" "titulo" => "Patients" ] 1 => array:2 [ "identificador" => "sec0020" "titulo" => "Study Protocol" ] 2 => array:2 [ "identificador" => "sec0025" "titulo" => "Instruments" ] 3 => array:2 [ "identificador" => "sec0030" "titulo" => "Measurements" ] 4 => array:2 [ "identificador" => "sec0035" "titulo" => "Statistical Analysis" ] ] ] 6 => array:2 [ "identificador" => "sec0040" "titulo" => "Results" ] 7 => array:3 [ "identificador" => "sec0045" "titulo" => "Discussion" "secciones" => array:1 [ 0 => array:2 [ "identificador" => "sec0050" "titulo" => "Limitations of the Study" ] ] ] 8 => array:2 [ "identificador" => "sec0055" "titulo" => "Conclusions" ] 9 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2015-06-10" "fechaAceptado" => "2015-11-19" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec684770" "palabras" => array:5 [ 0 => "6-Min walk test" 1 => "Chronic obstructive pulmonary disease" 2 => "Positive expiratory pressure" 3 => "Exercise capacity" 4 => "Distance covered" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec684769" "palabras" => array:5 [ 0 => "Prueba de marcha de 6<span class="elsevierStyleHsp" style=""></span>min" 1 => "Enfermedad pulmonar obstructiva crónica" 2 => "Presión espiratoria positiva" 3 => "Capacidad de ejercicio" 4 => "Distancia recorrida" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:3 [ "titulo" => "Abstract" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Background</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">The application of positive expiratory pressure (PEP) devices during exercise had been proposed in order to counteract the pulmonary hyperinflation, reduce the dyspnea and thus increase the exercise tolerance in patients with severe chronic obstructive pulmonary disease (COPD). This randomized controlled crossover trial investigated the effect of two different levels of PEP (1<span class="elsevierStyleHsp" style=""></span>cmH<span class="elsevierStyleInf">2</span>O and 10<span class="elsevierStyleHsp" style=""></span>cmH<span class="elsevierStyleInf">2</span>O) on distance covered at 6<span class="elsevierStyleHsp" style=""></span>min walk test (6MWT) in patients with severe COPD. Secondary outcomes were the evaluation of PEP effects on physiological and pulmonary function variables.</p></span> <span id="abst0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Methods</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Seventy-two severe COPD patients, referred to our hospitals as in and out patients, were recruited. A basal 6MWT without devices was performed on the first day, and then repeated with PEP 1<span class="elsevierStyleHsp" style=""></span>cmH<span class="elsevierStyleInf">2</span>O (PEP1) and 10<span class="elsevierStyleHsp" style=""></span>cmH<span class="elsevierStyleInf">2</span>O (PEP10), with a randomized crossover design. Slow and forced spirometries, including the inspiratory capacity measure, were repeated before and after each 6MWT.</p></span> <span id="abst0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Results</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">50 patients (average age 69.92 year, mean FEV<span class="elsevierStyleInf">1</span> 41.42% of predicted) concluded the trial. The 6MWT improved significantly among both PEP levels and baseline (323.8<span class="elsevierStyleHsp" style=""></span>mt at baseline vs 337.8 PEP1 and 341.8 PEP10; <span class="elsevierStyleItalic">P</span><.002 and <span class="elsevierStyleItalic">P</span><.018, respectively). The difference between PEP10 and PEP1 did not reach the significance. No improvements were found in pulmonary function, symptoms and physiological variables after the 6MWT.</p></span> <span id="abst0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Conclusions</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">In patients with severe COPD, the application of 1<span class="elsevierStyleHsp" style=""></span>cmH<span class="elsevierStyleInf">2</span>O of PEP seems to improve the exercise tolerance as 10<span class="elsevierStyleHsp" style=""></span>cmH<span class="elsevierStyleInf">2</span>O, with similar dyspnea. Further studies should investigate the effects of low levels of PEP on aerobic training programs.</p></span>" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Background" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Methods" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Results" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Conclusions" ] ] ] "es" => array:3 [ "titulo" => "Resumen" "resumen" => "<span id="abst0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Introducción</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">La aplicación de dispositivos de presión espiratoria positiva (PEP) durante el ejercicio se había propuesto con el objetivo de contrarrestar la hiperinflación pulmonar, reducir la disnea y mejorar así la tolerancia al ejercicio de los pacientes con enfermedad pulmonar obstructiva crónica (EPOC) grave. En este ensayo controlado, aleatorizado y cruzado se investigó el efecto de dos niveles de PEP (1<span class="elsevierStyleHsp" style=""></span>cm de H<span class="elsevierStyleInf">2</span>O y 10<span class="elsevierStyleHsp" style=""></span>cm de H<span class="elsevierStyleInf">2</span>O) sobre la distancia recorrida por pacientes con EPOC grave durante la prueba de marcha de 6<span class="elsevierStyleHsp" style=""></span>min (PM6<span class="elsevierStyleHsp" style=""></span>M). Los criterios de valoración secundarios fueron los efectos de la PEP sobre variables fisiológicas y de la función pulmonar.</p></span> <span id="abst0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Métodos</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Se reclutaron setenta y dos pacientes con EPOC grave, hospitalizados o ambulatorios, derivados a nuestros hospitales. El primer día de este estudio aleatorizado y cruzado se efectuó la PM6<span class="elsevierStyleHsp" style=""></span>M sin ningún dispositivo, y posteriormente se repitió con una PEP de 1<span class="elsevierStyleHsp" style=""></span>cm de H<span class="elsevierStyleInf">2</span>O (PEP1) y de 10<span class="elsevierStyleHsp" style=""></span>cm de H<span class="elsevierStyleInf">2</span>O (PEP10). Antes y después de cada PM6<span class="elsevierStyleHsp" style=""></span>M se practicaron espirometrías lentas y forzadas, que incluyeron la medición de la capacidad inspiratoria.</p></span> <span id="abst0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Resultados</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Cincuenta pacientes (edad media 69,92 años, FEV<span class="elsevierStyleInf">1</span> medio 41,42% del previsto) finalizaron el ensayo. La PM6<span class="elsevierStyleHsp" style=""></span>M mejoró significativamente con los dos niveles de PEP, en comparación con la situación inicial (323,8<span class="elsevierStyleHsp" style=""></span>m al inicio vs 337,8 con la PEP1 y 341,8 con la PEP10; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0,002 y <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0,018, respectivamente). La diferencia entre la PEP10 y la PEP1 no fue significativa. No se observaron mejorías en la función pulmonar, los síntomas ni las variables fisiológicas posteriores a la prueba PM6<span class="elsevierStyleHsp" style=""></span>M.</p></span> <span id="abst0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Conclusiones</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">En pacientes con EPOC grave, la aplicación de una PEP de 1<span class="elsevierStyleHsp" style=""></span>cm de H<span class="elsevierStyleInf">2</span>O parece mejorar la tolerancia al ejercicio, al igual que lo hace la aplicación de 10<span class="elsevierStyleHsp" style=""></span>cm H<span class="elsevierStyleInf">2</span>O y con un grado similar de disnea. Deben realizarse otros estudios para investigar los efectos de los niveles bajos de PEP en los programas de entrenamiento aeróbico.</p></span>" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0025" "titulo" => "Introducción" ] 1 => array:2 [ "identificador" => "abst0030" "titulo" => "Métodos" ] 2 => array:2 [ "identificador" => "abst0035" "titulo" => "Resultados" ] 3 => array:2 [ "identificador" => "abst0040" "titulo" => "Conclusiones" ] ] ] ] "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Russo D, Simonelli C, Paneroni M, Saleri M, Piroddi IMG, Cardinale F, et al. ¿Cuál es el nivel óptimo de presión espiratoria positiva (PEP) capaz de mejorar la tolerancia a la deambulación de los pacientes con EPOC grave? Arch Bronconeumol. 2016;52:354–360.</p>" ] ] "apendice" => array:1 [ 0 => array:1 [ "seccion" => array:1 [ 0 => array:4 [ "apendice" => "<p id="par0210" class="elsevierStylePara elsevierViewall"><elsevierMultimedia ident="tbl0005"></elsevierMultimedia></p>" "etiqueta" => "Appendix 1" "titulo" => "Available studies investigating the effects of PEP on exercise tolerance in patients with COPD" "identificador" => "sec0060" ] ] ] ] "multimedia" => array:6 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1212 "Ancho" => 1631 "Tamanyo" => 103179 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Patient disposition.</p>" ] ] 1 => array:7 [ "identificador" => "fig0010" "etiqueta" => "Fig. 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 1350 "Ancho" => 1636 "Tamanyo" => 80630 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Box plot of 6MWD without PEP (baseline), and using PEP1 and PEP10 cmH<span class="elsevierStyleInf">2</span>O.</p>" ] ] 2 => array:7 [ "identificador" => "tbl0010" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:2 [ "leyenda" => "<p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">BMI: body mass index; FVC: forced vital capacity; FEV<span class="elsevierStyleInf">1</span>: forced expiratory volume at the 1st second; TLC: total lung capacity; IC: inspiratory capacity; ERV: expiratory reserve volume; RV: residual volume; SpO<span class="elsevierStyleInf">2</span>: peripheral oxygen saturation; DL<span class="elsevierStyleSup">CO</span>: carbon monoxide diffusion capacity.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td-with-role" title="table-head ; entry_with_role_rowhead " align="left" valign="top" scope="col">Variable \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " colspan="2" align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Patients (<span class="elsevierStyleItalic">n</span>=50)</th></tr><tr title="table-row"><th class="td" title="table-head " align="" valign="top" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Mean \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">SD \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Sex (male), %</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">69.9 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">7.3 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="3" align="left" valign="top"><span class="elsevierStyleItalic">GOLD level, %</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>III \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">73.5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>IV \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">24.5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Long term oxygen therapy, %</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">24.5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Age, years</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">69.9 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">7.3 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">BMI</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">26.7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">6.3 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">FVC, %pred</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">69.56 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">15.83 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">FVC, L</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2.13 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.73 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">SVC, L</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2.21 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.76 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">FEV</span><span class="elsevierStyleInf"><span class="elsevierStyleItalic">1</span></span><span class="elsevierStyleItalic">, %pred</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">41.43 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">12.54 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">FEV</span><span class="elsevierStyleInf"><span class="elsevierStyleItalic">1</span></span><span class="elsevierStyleItalic">, L</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1.03 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.56 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">FEV</span><span class="elsevierStyleInf"><span class="elsevierStyleItalic">1</span></span><span class="elsevierStyleItalic">/FVC</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">49.43 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">14.63 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">TLC, %pred</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">114.71 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">27.27 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">IC, L</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1.59 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.54 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">ERV, L</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.78 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.49 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">RV, %pred</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">181.67 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">58.10 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">SpO</span><span class="elsevierStyleInf"><span class="elsevierStyleItalic">2</span></span><span class="elsevierStyleItalic">%</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">94.14 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2.33 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">DL</span><span class="elsevierStyleSup"><span class="elsevierStyleItalic">CO</span></span><span class="elsevierStyleItalic">(% pred)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">63.64 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">12.83 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Basal dyspnea, Borg score</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1.65 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1.93 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1114304.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">Anthropometrics and Baseline Characteristics of Patients Studied.</p>" ] ] 3 => array:7 [ "identificador" => "tbl0015" "etiqueta" => "Table 2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:2 [ "leyenda" => "<p id="spar0075" class="elsevierStyleSimplePara elsevierViewall">RR: respiratory rate; HR: heart rate; IC: inspiratory capacity; SVC: slow vital capacity; ERV: expiratory residual volume; FVC: forced vital capacity. The percentage of change has been calculated as Δ*100/basal value (at rest before starting the 6MWT).</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="" valign="top" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">No PEP \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">PEP1 \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">PEP10 \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">P</span> Value \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Final dyspnea, BORG scale \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">5.37 (2.32) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">5.18 (2.29) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">5.65 (2.43) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">.61 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Δdyspnea, BORG scale \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">3.91 (2.22) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">3.86 (2) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">3.47 (2.04) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">.52 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Δdyspnea% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">176 (172) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">244 (228) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">161 (157) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">.23 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Final leg fatigue, BORG scale \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">5.43 (1.36) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">4.90 (1.56) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">5.62 (1.22) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">.17 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Δleg fatigue, BORG scale \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">3.05 (1.16) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2.79 (0.82) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2.95 (0.86) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">.67 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Δleg fatigue% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">172 (145) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">188 (163) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">205 (95) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">.75 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Final RR, acts/min \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">25.75 (4.44) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">25.53 (5.53) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">25.88 (7.74) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">.94 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">ΔRR, acts/min \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">5.46 (3.87) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">4.37 (3.47) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">3.86 (3.66) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">.06 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">RR, % of change \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">28.7 (19.9) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">23.5 (22.7) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">19.3 (18.8) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">.10 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Final HR, beat/min \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">93.53 (13.77) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">97.10 (16.77) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">97.06 (16.53) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">.44 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">ΔHR, beat/min \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">18.61 (12.42) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">13.76 (9.67) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">16.30 (12.58) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">.07 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">HR, % change \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">25.4 (18.9) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">18.6 (15.5) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">21.2 (16.8) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">.15 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Final SpO<span class="elsevierStyleInf">2</span>, % \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">90.55 (5.66) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">91.82 (4.10) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">90.78 (6.81) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">.50 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">ΔSpO<span class="elsevierStyleInf">2</span>, % \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">−3.33 (6.25) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">−3.45 (4.96) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">−2.49 (3.89) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">.60 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">SpO<span class="elsevierStyleInf">2</span>, % change \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">−3.53 (6.68) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">−3.67 (5.41) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">−2.62 (4.15) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">.60 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">ΔIC, L \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.03 (0.21) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.04 (0.27) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">.90 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">IC, % change \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1.27 (15.72) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">3.42 (19.37) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">.56 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">ΔSVC, L \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.08 (0.23) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.10 (0.51) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">.82 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">SVC, % change \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2.87 (12.56) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">8.08 (37.11) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">.39 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">ΔERV, L \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">−0.02 (0.28) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">−0.06 (0.28) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">.50 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">ERV, % change \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">−15.91 (85.33) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">−30.04 (159.64) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">.60 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">ΔFVC, L \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.08 (0.19) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.15 (0.52) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">.40 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">FVC, % change \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">4.47 (10.15) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">11.02 (44.94) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">.34 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1114305.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0070" class="elsevierStyleSimplePara elsevierViewall">Changes in Secondary Outcomes Among Different PEP Settings, Mean (SD).</p>" ] ] 4 => array:7 [ "identificador" => "tbl0020" "etiqueta" => "Table 3" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:2 [ "leyenda" => "<p id="spar0085" class="elsevierStyleSimplePara elsevierViewall">6MWD: 6-min walk distance; PEP: positive expiratory pressure.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="" valign="top" scope="col"> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " colspan="3" align="center" valign="top" scope="col" style="border-bottom: 2px solid black">PEP1</th><th class="td" title="table-head " colspan="3" align="center" valign="top" scope="col" style="border-bottom: 2px solid black">PEP10</th></tr><tr title="table-row"><th class="td" title="table-head " align="" valign="top" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Patients \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Meters \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Δ Meters \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Patients \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Meters \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Δ Meters \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Patients with dynamic hyperinflation \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">10 (20%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">290 (95) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">−3.22 (21.98) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">8 (16.0%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">304 (132) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">14.42 (31.08) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Patients with no dynamic hyperinflation \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">40 (80%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">342 (124) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">20.83 (26.71) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">42 (84.0%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">345 (110) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">24.39 (31.91) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">P</span>-value \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">.24 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">.001 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">.38 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">.45 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1114306.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0080" class="elsevierStyleSimplePara elsevierViewall">Results in Covered Distance (6MWD) for Patients With or Without Dynamic Hyperinflation.</p>" ] ] 5 => array:5 [ "identificador" => "tbl0005" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => false "mostrarDisplay" => true "tabla" => array:2 [ "leyenda" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">FEV<span class="elsevierStyleInf">1</span>: forced expiratory volume 1st second; RV: residual volume; 6MWD: distance covered in 6-min walking test; TLC: total lung capacity; FRC: functional residual capacity; 1RM: 1 repetition maximum; IC: inspiratory capacity; VC: vital capacity; PLB: pursed lip breathing; MIP: maximal inspiratory pressure; MEP: maximal expiratory pressure; US: ultrasounds.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Authors \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Year \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Aim \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Study type \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Patients \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Protocol \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Primary outcome \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">PEP type \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Results \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Nicolini et al.<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">11</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2013 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">PEP utilization improves 6MWD? \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Prospective, randomized controlled, single blind \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">100 (50 controls) in-outpatients with moderate- to-severe COPD (%FEV1 51–49%, %RV 148–140%, mean basal 6MWD 232–262<span class="elsevierStyleHsp" style=""></span>mt). \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">6MWT at assessment, repeated after 30<span class="elsevierStyleHsp" style=""></span>min of rest with PEP in the intervention group, without devices in the control group. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">6MWT \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">5<span class="elsevierStyleHsp" style=""></span>cmH<span class="elsevierStyleInf">2</span>O threshold-PEP connected to mouthpiece with a tube (20<span class="elsevierStyleHsp" style=""></span>mm diameter, 100<span class="elsevierStyleHsp" style=""></span>mm length). \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">PEP improves 6MWD (+61 vs +3<span class="elsevierStyleHsp" style=""></span>mt, <span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.001). During 6MWT, PEP improves SpO<span class="elsevierStyleInf">2</span> and decreases FC (p<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.03); NS reduction of Borg Dyspnea and Respiratory Rate. \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="9" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Wibmer et al.<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">15</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2013 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Feasibility of a nasal PEP application during exercise, effects on dynamic hyperinflation. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Randomized, crossover. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">20 mild-moderate COPD (FEV<span class="elsevierStyleInf">1</span>>50%). \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">6MWT repeated twice (2–24<span class="elsevierStyleHsp" style=""></span>h of rest), with and without nasal PEP (crossover design), with subsequent spirometry and Borg dyspnea assessment. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">6MWD, spirometry \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Nasal mask with headgear, flow-dependent PEP 10–20<span class="elsevierStyleHsp" style=""></span>cmH<span class="elsevierStyleInf">2</span>O. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">PEP decreases TLC, FRC and RV (<span class="elsevierStyleItalic">P</span><.05), but produces also a significant reduction of 6MWD (−30.8<span class="elsevierStyleHsp" style=""></span>mt, <span class="elsevierStyleItalic">P</span>=.001). \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="9" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Martin et al.<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2011 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">PEP utilization reduces post-exercise dyspnea? \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Double blind, crossover. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">8 outpatients (4 controls) with COPD (FEV<span class="elsevierStyleInf">1</span><50%) and habitual use of pursed lip breathing. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Treadmill test repeated twice (crossover design). At the end of the test, the intervention group performed 6 breaths in threshold PEP, the control group in a sham-PEP. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Borg dyspnea \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">10<span class="elsevierStyleHsp" style=""></span>cmH<span class="elsevierStyleInf">2</span>O threshold PEP (13.8<span class="elsevierStyleHsp" style=""></span>cmH<span class="elsevierStyleInf">2</span>O if measured at the mouth) vs 2<span class="elsevierStyleHsp" style=""></span>cmH<span class="elsevierStyleInf">2</span>O sham-PEP. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">PEP reduces dyspnea 10<span class="elsevierStyleHsp" style=""></span>min after the exercise (post-exercise Borg dyspnea: 2.6 and 1.8 point, control and intervention group respectively, <span class="elsevierStyleItalic">P</span><.0001). \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="9" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Padkao et al.<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">11</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2010 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Conical-PEP reduces hyperinflation and increases exercise duration? \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Randomized, crossover. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">13 COPD moderate-to-severe (FEV<span class="elsevierStyleInf">1</span> 61%). \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Leg extension at 30% 1RM with ankle weights, 15 repetitions per min per leg, with and without PEP (crossover design). \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Spirometry (TLC, IC, slow VC) dyspnea, legs effort, exercise duration. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Flow-dependent conical-PEP 4–20<span class="elsevierStyleHsp" style=""></span>cmH<span class="elsevierStyleInf">2</span>O vs normal breathe. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">PEP produces an increase of IC and slow VC (+200<span class="elsevierStyleHsp" style=""></span>ml, <span class="elsevierStyleItalic">P</span>=.05), of the exercise duration (+107<span class="elsevierStyleHsp" style=""></span>s, <span class="elsevierStyleItalic">P</span>=.05), and a reduction of RR during exercise (−6.1<span class="elsevierStyleHsp" style=""></span>breath/min, <span class="elsevierStyleItalic">P</span>=.05), no adverse effects. \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="9" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Monteiro et al.<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">14</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2012 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Effect of PEP on inspiratory capacity. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Non-randomized, controlled. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">17 COPD (FEV<span class="elsevierStyleInf">1</span> 38%) with dynamic hyperinflation, defined as at least 15% decrease of IC after treadmill exercise. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Treadmill test lasting 20<span class="elsevierStyleHsp" style=""></span>min, with subsequent IC measure. If decreased at least of 15%, the test was repeated with PEP administration (timing not specified). \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">IC \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Oronasal mask with headgear and unidirectional valve, spring loaded PEP 5–10<span class="elsevierStyleHsp" style=""></span>cmH<span class="elsevierStyleInf">2</span>O. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">PEP produces an increase of IC (1.45<span class="elsevierStyleHsp" style=""></span>L and 1.13<span class="elsevierStyleHsp" style=""></span>L with and without PEP respectively, <span class="elsevierStyleItalic">P</span>=.02) and less IC decrease after exercise (−0.18<span class="elsevierStyleHsp" style=""></span>L and −0.57<span class="elsevierStyleHsp" style=""></span>L with and without PEP respectively, <span class="elsevierStyleItalic">P</span>=.02). \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="9" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Bhatt et al.<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">19</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2014 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Effect of pursed lip breathing on exercise capacity \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Randomized, crossover \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">14 COPD (FEV<span class="elsevierStyleInf">1</span> 38.4%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">6MWT at assessment, repeated with PLB \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">6MWT, spirometry, MIP, MEP, diaphragmatic excursion with US \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Volitional pursed lip breathing \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">PLB increases 6MWD (+34.9<span class="elsevierStyleHsp" style=""></span>mt, <span class="elsevierStyleItalic">P</span>=.002), reduces RR after 6MWT (−4.4<span class="elsevierStyleHsp" style=""></span>bpm, <span class="elsevierStyleItalic">P</span>=.003). Correlation between improvement in 6MWD and increase in diaphragmatic excursion with PLB. Greater improvement in patients with poorer baseline 6MWD. \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1114307.png" ] ] ] ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:28 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:2 [ 0 => "M.A. Spruit" 1 => "S.J. Singh" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/rccm.201309-1634ST" "Revista" => array:6 [ "tituloSerie" => "Am J Respir Crit Care Med" "fecha" => "2013" "volumen" => "188" "paginaInicial" => "e13" "paginaFinal" => "e64" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24127811" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Six-minute walk test: a valuable test tool for assessing pulmonary impairment" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "J.E. Morales-Blanhir" 1 => "C.D. Palafox Vidal" 2 => "M.J. Rosas Romero" 3 => "M.M. Garcia Castro" 4 => "A. Londono Villegas" 5 => "M. Zamboni" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Bras Pneumol" "fecha" => "2011" "volumen" => "37" "paginaInicial" => "120" "paginaFinal" => "127" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The walking capacity assessment in the respiratory patient" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "A. Chetta" 1 => "G. Pisi" 2 => "M. Aiello" 3 => "P. Tzani" 4 => "D. Olivieri" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1159/000212781" "Revista" => array:6 [ "tituloSerie" => "Respiration" "fecha" => "2009" "volumen" => "77" "paginaInicial" => "361" "paginaFinal" => "367" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19478551" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Exercise capacity as a pulmonary rehabilitation outcome" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "E.M. Clini" 1 => "E. Crisafulli" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1159/000192773" "Revista" => array:6 [ "tituloSerie" => "Respiration" "fecha" => "2009" "volumen" => "77" "paginaInicial" => "121" "paginaFinal" => "128" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19246958" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Peak physiologic responses to arm and leg ergometry in male and female patients with airflow obstruction" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "R. Carter" 1 => "D.B. Holiday" 2 => "J. Stocks" 3 => "B. Tiep" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Chest" "fecha" => "2000" "volumen" => "124" "paginaInicial" => "511" "paginaFinal" => "518" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12907536" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Exercise capacity and ventilator, circulatory, and symptom limitation in patients with chronic airflow limitation" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "K.J. Killian" 1 => "P. Leblanc" 2 => "D.H. Martin" 3 => "E. Summers" 4 => "N.L. Jones" 5 => "E.J. Campbell" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/ajrccm/146.4.935" "Revista" => array:6 [ "tituloSerie" => "Am Rev Resp Dis" "fecha" => "1992" "volumen" => "146" "paginaInicial" => "935" "paginaFinal" => "940" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/1416421" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Predictors of success and failure in pulmonary rehabilitation" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "R. Garrod" 1 => "J. Marshall" 2 => "E. Barley" 3 => "P.W. Jones" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1183/09031936.06.00130605" "Revista" => array:6 [ "tituloSerie" => "Eur Respir J" "fecha" => "2006" "volumen" => "27" "paginaInicial" => "788" "paginaFinal" => "794" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16481381" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Exercise outcomes after pulmonary rehabilitation depend on the initial mechanism of exercise limitation among non-oxygen dependent COPD patients" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "J.F. Plankeel" 1 => "B. McMullen" 2 => "N.R. MacIntyre" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1378/chest.127.1.110" "Revista" => array:6 [ "tituloSerie" => "Chest" "fecha" => "2005" "volumen" => "127" "paginaInicial" => "110" "paginaFinal" => "116" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15653970" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Exercise training in COPD: how to distinguish responders from nonresponders" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "T. Troosters" 1 => "R. Gosselink" 2 => "M. Decramer" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Cardiopulmonary Rehabil" "fecha" => "2001" "volumen" => "21" "paginaInicial" => "10" "paginaFinal" => "17" ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0050" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:1 [ "titulo" => "Non-invasive ventilation during exercise training for people with chronic obstructive pulmonary disease" ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/14651858.CD007714.pub2" "Revista" => array:3 [ "tituloSerie" => "Cochrane Database Syst Rev" "fecha" => "2014" "paginaInicial" => "5" ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0055" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Use of positive expiratory pressure during six minute walk test: results in patients with moderate to severe chronic obstructive pulmonary disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "A. Nicolini" 1 => "F. Merliak" 2 => "C. Barlascini" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Multidiscipl Resp Med" "fecha" => "2013" "volumen" => "8" "paginaInicial" => "19" ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0060" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pathogenesis of hyperinflation in chronic obstructive pulmonary disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "P. Gagnon" 1 => "J.A. Guenette" 2 => "D. Langer" 3 => "L. Laviolette" 4 => "V. Mainguy" 5 => "F. Maltais" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2147/COPD.S38934" "Revista" => array:6 [ "tituloSerie" => "Int J Chron Obstruct Pulmon Dis" "fecha" => "2014" "volumen" => "9" "paginaInicial" => "187" "paginaFinal" => "201" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24600216" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0065" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hyperinflation and its management in COPD" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "L. Puente-Maestu" 1 => "W.W. Stringer" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Int J Chron Obstruct Pulmon Dis" "fecha" => "2006" "volumen" => "1" "paginaInicial" => "381" "paginaFinal" => "400" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18044095" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0070" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Conical-PEP is safe, reduces lung hyperinflation and contributes to improved exercises endurance in patients with COPD: a randomized cross-over trial" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "T. Padkao" 1 => "W. Boonsawat" 2 => "U.J. Chulee" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Physiother" "fecha" => "2010" "volumen" => "56" "paginaInicial" => "33" "paginaFinal" => "39" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20500135" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0075" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Volitional pursed lips breathing in patients with stable chronic obstructive pulmonary disease improves exercise capacity" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S.P. Bhatt" 1 => "T.K. Luqman-Arafath" 2 => "A.K. Gupta" 3 => "A. Mohan" 4 => "J.C. Stoltzfus" 5 => "T. Dey" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Chronic Resp Dis" "fecha" => "2012" "volumen" => "10" "paginaInicial" => "5" "paginaFinal" => "10" ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0080" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effects of expiratory positive air way pressure on dynamic hyperinflation during exercise in patients with COPD" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "M.B. Monteiro" 1 => "D.C. Berton" 2 => "F.M. Moreira" 3 => "S.S. Menna-Barreto" 4 => "P.J. Zimermann Texeira" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.4187/respcare.01481" "Revista" => array:6 [ "tituloSerie" => "Respir Care" "fecha" => "2012" "volumen" => "57" "paginaInicial" => "1405" "paginaFinal" => "1412" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22348429" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0085" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Extrinsic threshold PEEP reduces post-exercise dyspnea in COPD patients: a placebo-controlled double-blind cross-over study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "A.D. Martin" 1 => "P.W. Davenport" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Cardiopulm Phys Ther J" "fecha" => "2011" "volumen" => "22" "paginaInicial" => "5" "paginaFinal" => "10" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22163175" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0090" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effects of nasal positive expiratory pressure on dynamic hyperinflation and 6-minute walk test in patients with COPD" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "T. Wibmer" 1 => "S. Ridiger" 2 => "C. Heitner" 3 => "C. Kropf-Sanchen" 4 => "I. Blanta" 5 => "K.M. Stoiber" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.4187/respcare.02668" "Revista" => array:6 [ "tituloSerie" => "Respir Care" "fecha" => "2014" "volumen" => "59" "paginaInicial" => "699" "paginaFinal" => "708" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24170913" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0095" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:1 [ "titulo" => "ATS statement: guidelines for six-minute walk, test" ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Am J Respir Crit Care Med" "fecha" => "2002" "volumen" => "166" "paginaInicial" => "150" "paginaFinal" => "153" ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0100" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Optimizing the 6-min walk test as a measure of exercise capacity" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "D. Chadra" 1 => "R.A. Wise" 2 => "H.S. Kulkarni" 3 => "R.P. Benzo" 4 => "G. Criner" 5 => "W.A. Slivka" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1378/chest.11-2702" "Revista" => array:6 [ "tituloSerie" => "Chest" "fecha" => "2012" "volumen" => "142" "paginaInicial" => "1545" "paginaFinal" => "1552" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23364913" "web" => "Medline" ] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0105" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "ATS/ERS Task Force: standardization of spirometry" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M.R. Miller" 1 => "J. Hankinson" 2 => "V. Brusasco" 3 => "F. Burgos" 4 => "R. Casaburi" 5 => "A. Coates" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1183/09031936.05.00034805" "Revista" => array:6 [ "tituloSerie" => "Eur Respir J" "fecha" => "2005" "volumen" => "26" "paginaInicial" => "319" "paginaFinal" => "338" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16055882" "web" => "Medline" ] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0110" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "D.E. O’Donnel" 1 => "S.M. Revill" 2 => "K.A. Webb" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/ajrccm.164.5.2012122" "Revista" => array:6 [ "tituloSerie" => "Am J Respir Crit Care Med" "fecha" => "2001" "volumen" => "164" "paginaInicial" => "770" "paginaFinal" => "777" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11549531" "web" => "Medline" ] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0115" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Upper limb exercise using varied workloads and their association with dynamic hyperinflation in patients with COPD" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Colucci" 1 => "F. Cortopassi" 2 => "E. Porto" 3 => "A. Castro" 4 => "F. Colucci" 5 => "V.C. Iamonti" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1378/chest.09-2878" "Revista" => array:6 [ "tituloSerie" => "Chest" "fecha" => "2010" "volumen" => "138" "paginaInicial" => "39" "paginaFinal" => "46" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20202941" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0120" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy of temporary positive expiratory pressure (TPEP) in patients with lung diseases and chronic mucus hypersecretion. The UNIKO<span class="elsevierStyleSup">®</span> project: a multicenter randomized controlled trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "E. Venturelli" 1 => "E. Crisafulli" 2 => "A. DeBiase" 3 => "D. Righi" 4 => "D. Berrighi" 5 => "P.P. Cavicchioli" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/0269215512458940" "Revista" => array:6 [ "tituloSerie" => "Clin Rehabil" "fecha" => "2013" "volumen" => "27" "paginaInicial" => "336" "paginaFinal" => "346" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22967853" "web" => "Medline" ] ] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0125" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Measurement of dynamic hyperinflation after a 6-minute walk test in patients with COPD" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "E. Callens" 1 => "S. Graba" 2 => "K. Gillet-Juvin" 3 => "M. Essalhi" 4 => "B. Bidaud-Chevalier" 5 => "C. Peiffer" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1378/chest.09-0410" "Revista" => array:6 [ "tituloSerie" => "Chest" "fecha" => "2009" "volumen" => "136" "paginaInicial" => "1466" "paginaFinal" => "1472" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19581350" "web" => "Medline" ] ] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0130" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Physiological responses to positive expiratory pressure breathing: a comparison of the PEP bottle and the PEP mask" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "M. Sehlin" 1 => "F. Ohberg" 2 => "G. Johannson" 3 => "O. Winso" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Resp Care" "fecha" => "2007" "volumen" => "52" "paginaInicial" => "1000" "paginaFinal" => "1005" ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib0135" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Updating the minimum important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "A.R. Holland" 1 => "C.J. Hill" 2 => "T. Rasebaka" 3 => "A. Lee" 4 => "M.T. Naughton" 5 => "C.F. McDonald" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Arch Phys Med Rehabil" "fecha" => "2010" "volumen" => "91" "paginaInicial" => "22" "paginaFinal" => "25" ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib0140" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Interpreting small differences in functional status: the six minute walk test in chronic lung disease patients" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "D.A. Redelmeier" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/ajrccm.155.4.9105067" "Revista" => array:6 [ "tituloSerie" => "Am J Respir Crit Care Med" "fecha" => "1997" "volumen" => "155" "paginaInicial" => "1278" "paginaFinal" => "1282" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9105067" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/15792129/0000005200000007/v2_201606300030/S1579212916000689/v2_201606300030/en/main.assets" "Apartado" => array:4 [ "identificador" => "9374" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Original Articles" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/15792129/0000005200000007/v2_201606300030/S1579212916000689/v2_201606300030/en/main.pdf?idApp=UINPBA00003Z&text.app=https://archbronconeumol.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212916000689?idApp=UINPBA00003Z" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 4 | 4 | 8 |
2024 October | 93 | 45 | 138 |
2024 September | 92 | 36 | 128 |
2024 August | 121 | 44 | 165 |
2024 July | 120 | 37 | 157 |
2024 June | 103 | 42 | 145 |
2024 May | 117 | 44 | 161 |
2024 April | 72 | 36 | 108 |
2024 March | 68 | 21 | 89 |
2024 February | 58 | 43 | 101 |
2024 January | 1 | 0 | 1 |
2023 March | 21 | 12 | 33 |
2023 February | 75 | 30 | 105 |
2023 January | 79 | 35 | 114 |
2022 December | 85 | 46 | 131 |
2022 November | 97 | 39 | 136 |
2022 October | 84 | 58 | 142 |
2022 September | 56 | 31 | 87 |
2022 August | 54 | 45 | 99 |
2022 July | 52 | 62 | 114 |
2022 June | 42 | 50 | 92 |
2022 May | 75 | 56 | 131 |
2022 April | 65 | 60 | 125 |
2022 March | 63 | 53 | 116 |
2022 February | 85 | 51 | 136 |
2022 January | 86 | 48 | 134 |
2021 December | 58 | 53 | 111 |
2021 November | 57 | 57 | 114 |
2021 October | 87 | 55 | 142 |
2021 September | 51 | 58 | 109 |
2021 August | 56 | 46 | 102 |
2021 July | 41 | 44 | 85 |
2021 June | 67 | 49 | 116 |
2021 May | 96 | 64 | 160 |
2021 April | 141 | 98 | 239 |
2021 March | 93 | 37 | 130 |
2021 February | 49 | 38 | 87 |
2021 January | 58 | 38 | 96 |
2020 December | 62 | 81 | 143 |
2020 November | 72 | 28 | 100 |
2020 October | 41 | 26 | 67 |
2020 September | 66 | 22 | 88 |
2020 August | 76 | 27 | 103 |
2020 July | 60 | 34 | 94 |
2020 June | 41 | 17 | 58 |
2020 May | 72 | 20 | 92 |
2020 April | 88 | 33 | 121 |
2020 March | 66 | 33 | 99 |
2020 February | 85 | 43 | 128 |
2020 January | 52 | 30 | 82 |
2019 December | 75 | 29 | 104 |
2019 November | 69 | 31 | 100 |
2019 October | 65 | 29 | 94 |
2019 September | 39 | 24 | 63 |
2019 August | 52 | 22 | 74 |
2019 July | 40 | 32 | 72 |
2019 June | 81 | 21 | 102 |
2019 May | 52 | 23 | 75 |
2019 April | 78 | 71 | 149 |
2019 March | 163 | 33 | 196 |
2019 February | 350 | 29 | 379 |
2019 January | 56 | 26 | 82 |
2018 December | 62 | 27 | 89 |
2018 November | 96 | 23 | 119 |
2018 October | 104 | 37 | 141 |
2018 September | 52 | 7 | 59 |
2018 May | 23 | 0 | 23 |
2018 April | 54 | 8 | 62 |
2018 March | 39 | 4 | 43 |
2018 February | 52 | 12 | 64 |
2018 January | 26 | 4 | 30 |
2017 December | 38 | 9 | 47 |
2017 November | 51 | 9 | 60 |
2017 October | 45 | 10 | 55 |
2017 September | 36 | 10 | 46 |
2017 August | 28 | 12 | 40 |
2017 July | 31 | 14 | 45 |
2017 June | 39 | 15 | 54 |
2017 May | 54 | 16 | 70 |
2017 April | 27 | 18 | 45 |
2017 March | 22 | 13 | 35 |
2017 February | 19 | 5 | 24 |
2017 January | 17 | 16 | 33 |
2016 December | 36 | 25 | 61 |
2016 November | 46 | 38 | 84 |
2016 October | 49 | 35 | 84 |
2016 September | 0 | 2 | 2 |